Bristol-Myers spends more, faces rising competition
543192
Bristol-Myers Squibb Co. reported a 16% drop in third-quarter profits as some of its products faced increased competition and it spent more money on research and development.
550994
How to benefit from increased spending on preventative medicine.
582476
Charges to retire debt and finance the proposed settlement of a probe into its marketing practices more than offset strong sales growth at Bristol-Myers, which posted a loss of $133 million.
731230
The biotech mines extra value from its compound library.
619348
During the past few months some of the world's largest life-sciences firms -- desperate for new products and technology -- have gone shopping in, of all places, Gaithersburg.
634762
Although problems still hang over the company, Bristol-Myers is paving the way for recovery.
167493
It appears competition is starting to heat up in this insurance sector.
727152
New developments are brewing at the pharmaceutical.
728273
Although a U.S. judge has halted  continued shipments of a generic form of Bristol-Myers Squibb  Co.'s  best-selling drug, analysts on Friday cautioned  that huge supplies already on the market would hurt the  company's earnings in 2006 and 2007.
383565
Bristol-Myers Squibb Co.  on Friday reported a lower third-quarter profit as revenue fell amid intense competition for its products from rivals and generic drugs.
494484
LONDON/PARIS  - U.S. pharmaceutical company Bristol-Myers Squibb has hired additional Wall Street banks ahead of a possible offer from French peer Sanofi-Aventis, people familiar with the situation said on Wednesday.
738382
The drug maker is poised to speed past its rivals.
151888
Shares of both Bristol-Myers Squibb and Sanofi-Aventis traded heavily on speculation that the companies might merge to form one of the worldâs largest drug companies.
94220
While bigger competitors stumble over each other, Bio-Reference keeps growing.
501888
Bristol-Myers Squibb Co., a major drug maker, third-quarter profits fell 16 percent as the company struggles with the loss of patent protection on key products but also increases spending on research and development.
686569
International expansion is becoming increasingly important to retailers as they face fierce competition at home, a new report finds.
421804
Abbott Laboratories Inc. ABT.N is  betting $1 billion in deals and the start of a new clinical  trial will finally get Wall Street to focus on its  cardiovascular device business.